StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Demecariumbromid

Demecarium Bromide

HCID 5965
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
56-94-0
Standard-SMILES
CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-].[Br-]
InChIKey
YHKBUDZECQDYBR-UHFFFAOYSA-L
Summenformel
C32H52Br2N4O4
Durchschnittliche Molmasse
716,6 g/mol
Monoisotopische Masse
714,23553

Überblick

Demecarium bromide is the methobromide salt of the N,N'-bis[3-(dimethylamino)phenyl carbamate] derivative of 2,13-diazatetradecane. It is an inhibitor of acetylcholinesterase and pseudocholinesterase, with a long duration of action. It is used in the treatment of chronic open-angle glaucoma: in the eye, it causes constriction of the iris sphincter muscle and the ciliary muscle, facilitating the outflow of the aqueous humor and so reducing intraocular pressure. It has a role as an EC 3.1.1.8 (cholinesterase) inhibitor and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a bromide salt, a carbamate ester and a quaternary ammonium salt. It contains a demarcarium.

Namen und Bezeichner

Bevorzugter Name
Demecarium Bromide
IUPAC
trimethyl-[3-[methyl-[10-[methyl-[3-(trimethylazaniumyl)phenoxy]carbonylamino]decyl]carbamoyl]oxyphenyl]azanium dibromide
Lokaler Name
Demecariumbromid
Englischer Name
Demecarium bromide
Summenformel
C32H52Br2N4O4
Molmasse
716.59

Namen und Synonyme

DEMECARIUM BROMIDE56-94-0HumorsolFrumtosnilVisumioticTonilenTosmicilTosmileneVisumaticBromuro de demecarioBromure de demecariumDemekastigmine bromide
Weitere Namen anzeigen
Demecarium2brbc48e)(2:1)tosmilen
Demecarii bromidumDemekarium bromideBC 4861D5V4OKTPN,N'-Bis(3-trimethylammoniumphenoxycarbonyl)-N,N'-dimethyldecamethylenediamine dibromideBC-48(m-Hydroxyphenyl)trimethylammonium bromide decamethylenebis(methylcarbamate)(m-Hydroxyphenyl)trimethylammonium bromide decamethylenebis(methylcarbamate) (2:1)

Datenbank-Bezeichner

CAS
56-94-0
PubChem CID
5965
ChEMBL
CHEMBL1200514
ChEBI
CHEBI:4391
UNII
61D5V4OKTP
EC Number
200-301-9

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
59,1 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
17
Schwere Atome
42
Formalladung
0
Komplexität
686

Experimentelle und physikochemische Eigenschaften

pHAQ SOLN ARE NEUTRAL
Color/Form · 2 Einträge

WHITE POWDER

SLIGHTLY YELLOW, CRYSTALLINE POWDER

SolubilityFREELY SOL IN WATER, ALCOHOL; SPARINGLY SOL IN ACETONE; INSOL IN ETHER
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Stability/Shelf Life · 2 Einträge

AQ SOLN ARE STABLE

STABLE TO AUTOCLAVING, & RETAIN THEIR POTENCY FOR PROLONGED PERIODS

Other Experimental Properties · 3 Einträge

DECOMP @ 162-167 °C

CONSISTS OF 2 NEOSTIGMINE MOLECULES CONNECTED @ CARBAMATE NITROGEN ATOMS BY SERIES OF 10 METHYLENE GROUPS /DEMECARIUM/

SLIGHTLY HYGROSCOPIC

Physikochemische Eigenschaften

Schmelzpunkt
162 · 162-167 °C (decomp)
storage temp.
-20 °C · Store at -20°C

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 2 (100%)

Toxikologische Informationen

Interactions...INHIBITION PRODUCED BY DEMECARIUM IS "REVERSIBLE". LOCAL EFFECTS OF DRUG CAN BE ANTAGONIZED BY ATROPINE AS WELL AS BY PRALIDOXIME (PROTOPAM). EFFECTS OF DEMECARIUM ARE NOT INHIBITED BY PRIOR INSTILLATION OF PHYSOSTIGMINE. /DEMECARIUM/
Human Toxicity Excerpts · 5 Einträge

IN SOME PT, DEMECARIUM MAY PRODUCE CONTACT DERMATITIS. IRIS CYSTS HAVE BEEN REPORTED, PARTICULARLY IN CHILDREN, FOLLOWING PROLONGED USE... /DEMECARIUM/

SIDE EFFECTS OF DEMECARIUM...MAY INCL CILIARY OR ACCOMODATIVE SPASM, BLURRED VISION, OCULAR OR BROW PAIN, HEADACHE, PHOTOPHOBIA, & TWITCHING OF EYELIDS. RARELY, RETINAL DETACHMENT MAY RESULT FROM SEVERE CILIARY SPASM. CONGESTIVE IRITIS, IRIDOCYCLITIS, & CONJUNCTIVAL & INTRAOCULAR HYPEREMIA MAY...OCCUR. /DEMECARIUM/

SYSTEMIC EFFECTS ARE MANIFESTATIONS OF PARASYMPATHETIC STIMULATION & MAY INCL NAUSEA, VOMITING, ABDOMINAL PAIN, DIARRHEA, FREQUENT URINATION, EXCESSIVE SALIVATION & SWEATING, FLUSHING, BRONCHIAL CONSTRICTION, HYPOTENSION, & BRADYCARDIA. ...INGESTION...WILL PRODUCE SIMILAR...EFFECTS &...CONVULSIONS, SHOCK & COLLAPSE.

IT HAS NOW BEEN ESTABLISHED THAT TREATMENT OF GLAUCOMA WITH POTENT, LONG-ACTING ANTI-CHOLINESTERASE AGENTS (INCL DEMECARIUM...) FOR 6 MO OR LONGER CARRIES HIGH RISK OF DEVELOPMENT OF SPECIFIC TYPE OF CATARACT, DESCRIBED AS ANTERIOR SUBCAPSULAR VACUOLES... INCIDENCE OF LENTICULAR OPACITIES...AS HIGH AS 50%... /DEMECARIUM/

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 2 Einträge

/INCR FACILITY OF AQ OUTFLOW/...ACCOMPANIED BY VASODILATATION OF CONJUNCTIVAL VESSELS & INCR PERMEABILITY OF BLOOD-AQ BARRIER. INDIRECT DECR IN ACTIVITY OF EXTRAOCULAR MUSCLES OF CONVERGENCE ALSO OCCURS. ...CHOLINESTERASE INHIBITION PRODUCED BY DEMECARIUM IS "REVERSIBLE".

DEMECARIUM BROMIDE...IS A QUATERNARY AMMONIUM ANTICHOLINESTERASE DRUG. ... RESULTING ACCUM OF ACETYLCHOLINE PRODUCES MIOSIS & STIMULATES CILIARY MUSCLE...REDUCING INTRAOCULAR PRESSURE BY INCR FACILITY OF AQ OUTFLOW.

MeSH Pharmacological Classification · 1 Eintrag

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.

Absorption, Distribution and ExcretionDEMECARIUM IS ABSORBED THROUGH CONJUNCTIVAL SAC AS WELL AS THROUGH INTACT SKIN... /DEMECARIUM/

Verwendung und Herstellung

Uses · 2 Einträge

MEDICATION

MEDICATION (VET)

Methods of Manufacturing · 2 Einträge

N,N'-DIMETHYL-1,10-DECAMETHYLENEDIAMINE IS ADDED TO MOLTEN 3-(DIMETHYLAMINO)PHENYL CARBONATE TO PRODUCE 1,10-DE CAMETHYLENEBIS[3-(DIMETHYL-AMINO)PHENYL N-METHYLCARBAMATE]. AFTER PURIFICATION THIS ESTER...A VISCOUS OIL, IS DISSOLVED IN ETHANOL & DOUBLY QUATERNIZED WITH AID OF AN ACETONE SOLN OF METHYL BROMIDE.

SCHMID, US PATENT 2,789,981 (1957 TO OESTERREICHISCHE STICKSTOFFWERKE).

Formulations/Preparations

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Löslichkeit
160 · DMSO:160.0(Max Conc. mg/mL);223.28(Max Conc. mM)
Aggregatzustand
Solid
Farbe
White
Major Application
pharmaceutical (small molecule)
InChIKey
YHKBUDZECQDYBR-UHFFFAOYSA-L
SMILES
C1(=CC=CC([N+](C)(C)C)=C1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1.[Br-].[Br-]
CAS Datenbank
56 · 56-94-0(CAS DataBase Reference)

For more Human Toxicity Excerpts (Complete) data for DEMECARIUM BROMIDE (6 total), please visit the HSDB record page.

Drug Induced Liver Injury · 4 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

demecarium bromide

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 2 Einträge

SYSTEMIC ABSORPTION FROM NOSE CAN OCCUR, CAUSING TREMORS & COLLAPSE.

NEUROACTIVE COMPD & VERTEBRAL TERATOGENESIS IN BIRD EMBRYO. QUAIL EMBRYOS EXPOSED TO DEMECARIUM BROMIDE (1.5 MG) SHOWED VERTEBRAL FUSIONS & NECK DEFORMITIES AFTER 3 DAYS. MECHANISM OF TERATOGENESIS IS DISCUSSED.

Antidote and Emergency Treatment · 3 Einträge

...SYSTEMIC TOXICITY, ATROPINE SULFATE OR PRALIDOXIME CHLORIDE, ADMIN SC OR IV, IS EFFECTIVE ANTIDOTE. ADMIN OF SHORT-ACTING BARBITURATE MAY ALSO BE NECESSARY & ARTIFICIAL RESPIRATION MAY BE REQUIRED TO MAINTAIN ADEQUATE VENTILATION.

MARKED INCR IN INTRAOCULAR PRESSURE MAY BE OVERCOME BY LOCAL INSTILLATION OF EPINEPHRINE IF NECESSARY. ... SEVERE HYPEREMIA MAY BE RELIEVED BY LOCAL INSTILLATION OF 1 OR 2% EPINEPHRINE.

APPEARANCE OF.../IRIS CYSTS/ HAS BEEN ATTRIBUTED TO FREQUENCY OF ADMIN & THEY HAVE DISAPPEARED UPON WITHDRAWAL OF DRUG. PT SHOULD BE EXAMINED REGULARLY FOR APPEARANCE OF IRIS CYSTS & THERAPY SHOULD BE DISCONTINUED, AT LEAST TEMPORARILY, IF THEY OCCUR.

Sicherheitsdaten

wgk
WGK 3
hs_code
2924296000
Speicherklasse
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
Giftige Stoffe Daten
56-94-0(Hazardous Substances Data)
Hazard Classifications
Acute Tox. 2 Oral
DEMECARIUM BROMIDE: HUMORSOL (MERCK SHARP & DOHME). TOPICAL: AQ SOLN (OPHTHALMIC, STERILE) 0.125% & 0.25% WITH SODIUM CHLORIDE & BENZALKONIUM CHLORIDE IN 5 ML CONTAINERS.
Anwendungen · 2 Einträge

VerwendenDemecarium is a disymmetrical compound that contains two ammonium and two carbamate groups. It is a reversible cholinesterase inhibitor that is longer lasting than the others. It is used to constrict pupils, elevate intraocular pressure in treating glaucoma, and also for alleviating atropine mydriasis.

VerwendenDemecarium Bromide is an acetylcholinesterase inhibitor and veterinary medicine used to treat elevated intraocular pressure associated with primary glaucoma.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Brommethan3-DimethylaminophenolCarbonylchloridNatrium
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: The methobromide salt of the N,N'-bis[3-(dimethylamino)phenyl carbamate] derivative of 2,13-diazatetradecane. It is an inhibitor of acetylcholinesterase and pseudocholinesterase, with a long duration of action. It is u ed in the treatment of chronic open-angle glaucoma: in the eye, it causes constriction of the iris sphincter muscle and the ciliary muscle, facilitating the outflow of the aqueous humor and so reducing intraocular pressure.